Edwards Receives CE Mark For PASCAL Transcatheter Tricuspid Valve Repair System
Executive Summary
Edwards Lifesciences received the CE mark for its PASCAL transcatheter system for treating triscupid valve regurgitation, competing against Abbott’s newly CE-marked TriClip.
You may also be interested in...
Cardio Catch-Up: Medtronic Plans To Buy Cathworks, Edwards Delays Evoque CE Mark, And More
Part II of highlights the cardiovascular tech sectors includes news from Medtronic, Edwards Lifesciences, and Abbott, plus a look at the upcoming TCT Conference in Boston.
Abbott Gains CE Marks For New Tricuspid Device And Expanded Xience DES Indication
The next-generation TriClip G4 comes in more sizes than the original TriClip and features enhanced leaflet grasping features.
Medtronic Launches Trial Of Tricuspid Version Of Intrepid Transcatheter Valve
The company is sponsoring an early feasibility trial of the Intrepid transcatheter valve replacement system for patients with severe tricuspid regurgitation.